insurers
Most Read
No products yet, but ambitious Atul Gawande health venture to begin ‘deploying tests’ this year
In a heated court hearing, Atul Gawande’s new company and Optum fight to keep their own secrets
Trade secrets case involving Atul Gawande’s company raises a key question: Who counts as a threat?
Senators press insurers for reams of pricing and rebate info on insulin
As blockbuster drugs fizzle, biotech looks warily to the next big thing
The backlash over high drug prices is hitting pharma where it hurts
